Use of interleukin 15 to enhance interferon-γ production by antigen-specific stimulated lymphocytes from rhesus macaques

Sandra A. Calarota, Miguel Otero, Keith Hermanstayne, Mark Lewis, Margherita Rosati, Barbara K. Felber, George N. Pavlakis, Jean D. Boyer, David B. Weiner

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

The enzyme-linked immune spot (ELISPOT) assay is receiving increased attention as a means for quantifying antigen-specific CD8 T-cell responses in rhesus macaques. Further improving the sensitivity of this assay could aid in the evaluation of vaccine candidates and/or immune therapeutic candidates. Interleukin (IL)-15 has been demonstrated to stimulate expansion of human immunodeficiency virus (HIV)-specific cytotoxic T lymphocytes (CTL) and to regulate homeostatic proliferation of CD8+ memory cells. We evaluated the in vitro effect of IL-15 to increase the detection of interferon-γ (IFN-γ) production by antigen-specific stimulated lymphocytes from a group of rhesus macaques exposed to simian-human immunodeficiency virus (SHIV) and a second group infected with SIVmac251, before and after antiretroviral treatment (ART). Results from these studies demonstrate that the presence of IL-15 during stimulation in a peptide-based ELISPOT assay greatly enhanced IFN-γ production in both SHIV and simian immunodeficiency virus (SIV)-infected macaques. IFN-γ production was mainly mediated by CD8 lymphocytes. The optimal concentrations of IL-15 that give enhancement of IFN-γ production to specific antigen, without a significant increase in the spontaneous IFN-γ release, ranged from 0.5 to 2.5 ng/ml. The mean number of IFN-γ spots was increased 3.1- to 3.6-fold in response to SIV gag or HIV env peptide pools, respectively, in peripheral blood mononuclear cells (PBMC) from SHIV-infected macaques. Similarly, in SIV-infected macaques, IL-15 increased the mean number of IFN-γ spots 2.7-fold in response to both SIV gag and env peptide pools. In samples obtained after ART in the same macaques, the increase factor was 2.5 for SIV gag and 1.8 for the env peptide pools. Thus, the sensitivity of the ELISPOT assay can be enhanced by addition of IL-15. This modified assay will be useful for detection of low frequencies of IFN-γ producing cells in rhesus macaques.

Original languageEnglish
Pages (from-to)55-67
Number of pages13
JournalJournal of Immunological Methods
Volume279
Issue number1-2
DOIs
Publication statusPublished - Aug 2003

Fingerprint

Interleukin-15
Simian Immunodeficiency Virus
Macaca mulatta
Interferons
Lymphocytes
Antigens
Macaca
HIV
Peptides
Enzymes
CD8 Antigens
Cytotoxic T-Lymphocytes
Blood Cells
Vaccines
T-Lymphocytes

Keywords

  • ELISPOT
  • IL-15
  • Interferon-γ
  • Rhesus macaques

ASJC Scopus subject areas

  • Biotechnology
  • Immunology

Cite this

Use of interleukin 15 to enhance interferon-γ production by antigen-specific stimulated lymphocytes from rhesus macaques. / Calarota, Sandra A.; Otero, Miguel; Hermanstayne, Keith; Lewis, Mark; Rosati, Margherita; Felber, Barbara K.; Pavlakis, George N.; Boyer, Jean D.; Weiner, David B.

In: Journal of Immunological Methods, Vol. 279, No. 1-2, 08.2003, p. 55-67.

Research output: Contribution to journalArticle

Calarota, SA, Otero, M, Hermanstayne, K, Lewis, M, Rosati, M, Felber, BK, Pavlakis, GN, Boyer, JD & Weiner, DB 2003, 'Use of interleukin 15 to enhance interferon-γ production by antigen-specific stimulated lymphocytes from rhesus macaques', Journal of Immunological Methods, vol. 279, no. 1-2, pp. 55-67. https://doi.org/10.1016/S0022-1759(03)00246-1
Calarota, Sandra A. ; Otero, Miguel ; Hermanstayne, Keith ; Lewis, Mark ; Rosati, Margherita ; Felber, Barbara K. ; Pavlakis, George N. ; Boyer, Jean D. ; Weiner, David B. / Use of interleukin 15 to enhance interferon-γ production by antigen-specific stimulated lymphocytes from rhesus macaques. In: Journal of Immunological Methods. 2003 ; Vol. 279, No. 1-2. pp. 55-67.
@article{047bfa7937f04b759502a465d74b5874,
title = "Use of interleukin 15 to enhance interferon-γ production by antigen-specific stimulated lymphocytes from rhesus macaques",
abstract = "The enzyme-linked immune spot (ELISPOT) assay is receiving increased attention as a means for quantifying antigen-specific CD8 T-cell responses in rhesus macaques. Further improving the sensitivity of this assay could aid in the evaluation of vaccine candidates and/or immune therapeutic candidates. Interleukin (IL)-15 has been demonstrated to stimulate expansion of human immunodeficiency virus (HIV)-specific cytotoxic T lymphocytes (CTL) and to regulate homeostatic proliferation of CD8+ memory cells. We evaluated the in vitro effect of IL-15 to increase the detection of interferon-γ (IFN-γ) production by antigen-specific stimulated lymphocytes from a group of rhesus macaques exposed to simian-human immunodeficiency virus (SHIV) and a second group infected with SIVmac251, before and after antiretroviral treatment (ART). Results from these studies demonstrate that the presence of IL-15 during stimulation in a peptide-based ELISPOT assay greatly enhanced IFN-γ production in both SHIV and simian immunodeficiency virus (SIV)-infected macaques. IFN-γ production was mainly mediated by CD8 lymphocytes. The optimal concentrations of IL-15 that give enhancement of IFN-γ production to specific antigen, without a significant increase in the spontaneous IFN-γ release, ranged from 0.5 to 2.5 ng/ml. The mean number of IFN-γ spots was increased 3.1- to 3.6-fold in response to SIV gag or HIV env peptide pools, respectively, in peripheral blood mononuclear cells (PBMC) from SHIV-infected macaques. Similarly, in SIV-infected macaques, IL-15 increased the mean number of IFN-γ spots 2.7-fold in response to both SIV gag and env peptide pools. In samples obtained after ART in the same macaques, the increase factor was 2.5 for SIV gag and 1.8 for the env peptide pools. Thus, the sensitivity of the ELISPOT assay can be enhanced by addition of IL-15. This modified assay will be useful for detection of low frequencies of IFN-γ producing cells in rhesus macaques.",
keywords = "ELISPOT, IL-15, Interferon-γ, Rhesus macaques",
author = "Calarota, {Sandra A.} and Miguel Otero and Keith Hermanstayne and Mark Lewis and Margherita Rosati and Felber, {Barbara K.} and Pavlakis, {George N.} and Boyer, {Jean D.} and Weiner, {David B.}",
year = "2003",
month = "8",
doi = "10.1016/S0022-1759(03)00246-1",
language = "English",
volume = "279",
pages = "55--67",
journal = "Journal of Immunological Methods",
issn = "0022-1759",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Use of interleukin 15 to enhance interferon-γ production by antigen-specific stimulated lymphocytes from rhesus macaques

AU - Calarota, Sandra A.

AU - Otero, Miguel

AU - Hermanstayne, Keith

AU - Lewis, Mark

AU - Rosati, Margherita

AU - Felber, Barbara K.

AU - Pavlakis, George N.

AU - Boyer, Jean D.

AU - Weiner, David B.

PY - 2003/8

Y1 - 2003/8

N2 - The enzyme-linked immune spot (ELISPOT) assay is receiving increased attention as a means for quantifying antigen-specific CD8 T-cell responses in rhesus macaques. Further improving the sensitivity of this assay could aid in the evaluation of vaccine candidates and/or immune therapeutic candidates. Interleukin (IL)-15 has been demonstrated to stimulate expansion of human immunodeficiency virus (HIV)-specific cytotoxic T lymphocytes (CTL) and to regulate homeostatic proliferation of CD8+ memory cells. We evaluated the in vitro effect of IL-15 to increase the detection of interferon-γ (IFN-γ) production by antigen-specific stimulated lymphocytes from a group of rhesus macaques exposed to simian-human immunodeficiency virus (SHIV) and a second group infected with SIVmac251, before and after antiretroviral treatment (ART). Results from these studies demonstrate that the presence of IL-15 during stimulation in a peptide-based ELISPOT assay greatly enhanced IFN-γ production in both SHIV and simian immunodeficiency virus (SIV)-infected macaques. IFN-γ production was mainly mediated by CD8 lymphocytes. The optimal concentrations of IL-15 that give enhancement of IFN-γ production to specific antigen, without a significant increase in the spontaneous IFN-γ release, ranged from 0.5 to 2.5 ng/ml. The mean number of IFN-γ spots was increased 3.1- to 3.6-fold in response to SIV gag or HIV env peptide pools, respectively, in peripheral blood mononuclear cells (PBMC) from SHIV-infected macaques. Similarly, in SIV-infected macaques, IL-15 increased the mean number of IFN-γ spots 2.7-fold in response to both SIV gag and env peptide pools. In samples obtained after ART in the same macaques, the increase factor was 2.5 for SIV gag and 1.8 for the env peptide pools. Thus, the sensitivity of the ELISPOT assay can be enhanced by addition of IL-15. This modified assay will be useful for detection of low frequencies of IFN-γ producing cells in rhesus macaques.

AB - The enzyme-linked immune spot (ELISPOT) assay is receiving increased attention as a means for quantifying antigen-specific CD8 T-cell responses in rhesus macaques. Further improving the sensitivity of this assay could aid in the evaluation of vaccine candidates and/or immune therapeutic candidates. Interleukin (IL)-15 has been demonstrated to stimulate expansion of human immunodeficiency virus (HIV)-specific cytotoxic T lymphocytes (CTL) and to regulate homeostatic proliferation of CD8+ memory cells. We evaluated the in vitro effect of IL-15 to increase the detection of interferon-γ (IFN-γ) production by antigen-specific stimulated lymphocytes from a group of rhesus macaques exposed to simian-human immunodeficiency virus (SHIV) and a second group infected with SIVmac251, before and after antiretroviral treatment (ART). Results from these studies demonstrate that the presence of IL-15 during stimulation in a peptide-based ELISPOT assay greatly enhanced IFN-γ production in both SHIV and simian immunodeficiency virus (SIV)-infected macaques. IFN-γ production was mainly mediated by CD8 lymphocytes. The optimal concentrations of IL-15 that give enhancement of IFN-γ production to specific antigen, without a significant increase in the spontaneous IFN-γ release, ranged from 0.5 to 2.5 ng/ml. The mean number of IFN-γ spots was increased 3.1- to 3.6-fold in response to SIV gag or HIV env peptide pools, respectively, in peripheral blood mononuclear cells (PBMC) from SHIV-infected macaques. Similarly, in SIV-infected macaques, IL-15 increased the mean number of IFN-γ spots 2.7-fold in response to both SIV gag and env peptide pools. In samples obtained after ART in the same macaques, the increase factor was 2.5 for SIV gag and 1.8 for the env peptide pools. Thus, the sensitivity of the ELISPOT assay can be enhanced by addition of IL-15. This modified assay will be useful for detection of low frequencies of IFN-γ producing cells in rhesus macaques.

KW - ELISPOT

KW - IL-15

KW - Interferon-γ

KW - Rhesus macaques

UR - http://www.scopus.com/inward/record.url?scp=0142061097&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0142061097&partnerID=8YFLogxK

U2 - 10.1016/S0022-1759(03)00246-1

DO - 10.1016/S0022-1759(03)00246-1

M3 - Article

C2 - 12969547

AN - SCOPUS:0142061097

VL - 279

SP - 55

EP - 67

JO - Journal of Immunological Methods

JF - Journal of Immunological Methods

SN - 0022-1759

IS - 1-2

ER -